A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma.
(Q44116644)
scientific article published in September 2002
scientific article published in September 2002
Language:
Current Data About
A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma.